Nadia Waheed
Chief Medical Officer at Ocular Therapeutix, Inc (OCUL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $221K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 5SEC | OCULOcular Therapeutix, Inc | Sell Plan | 14,828300,079 held (−5%) | $8.27 | $123K | -16.9% |
| Feb 24SEC | OCULOcular Therapeutix, Inc | Sell Plan | 3,510314,907 held (−1%) | $7.74 | $27K | -11.2% |
| Feb 17SEC | OCULOcular Therapeutix, Inc | Sell Plan | 7,863318,417 held (−2%) | $9.04 | $71K | -24.0% |
- Sell
Chief Medical Officer Nadia Waheed sold $123K of OCUL at $8.27 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Nadia Waheed sold $27K of OCUL at $7.74 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Nadia Waheed sold $71K of OCUL at $9.04 — pre-scheduled 10b5-1 plan sale.